Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, December 10, 2021
ATMPS Ltd/Hataali – a provider of blockchain-based data sharing platforms for advanced therapies – announced a new strategic partnership with Assurea LLC, the USA-based quality and compliance consultancy.
read more
AtkinsRéalis Group Inc. an engineering services and nuclear company has been chosen by Jubilant HollisterStier to provide detailed design for the expansion of their sterile injectable facility in Montreal as part of Canada's Biomanufacturing and Life...
read more
Thursday, December 27, 2018
Athenex announced the launch of Levothyroxine Sodium for Injection through its subsidiary Athenex Pharmaceutical Division (APD).
read more
Thursday, September 03, 2020
Atelerix has received an award under the UK Innovation and Science Seed Fund (UKI2S) Accelerator Programme from Innovate UK, the UK’s innovation agency.
read more
Wednesday, September 03, 2025
Atelerix, a cell preservation and biological transport company, announced an agreement with Rodon Global, a freight company focused on clinical trials and drug discovery headquartered in South Africa. The collaboration comes at a pivotal time as ...
read more
Thursday, October 08, 2020
ATCC announced a potential 10-year, IDIQ contract award with a ceiling value of $250 million from the BARDA, a division of the Office of the Assistant Secretary for Preparedness and Response with the HHS.
read more
ATCC has entered into an agreement with QIAGEN to provide them with sequencing data from its collection of cell lines, and animal and human biological materials. QIAGEN Digital Insights, the bioinformatics unit of QIAGEN, will establish a database ...
read more
Wednesday, October 19, 2016
ATCC, a global provider of biological materials development, management and standards, and BioAgilytix, a provider of contract testing services with a specialization in biologics, have announced a strategic partnership to develop new and custom cell-...
read more
Thursday, January 27, 2022
Atara Biotherapeutics, Inc. has entered into a long term strategic agreement with FUJIFILM Diosynth Biotechnologies (FDB), a subsidiary of FUJIFILM Corporation under which Fujifilm will acquire Atara’s T-Cell Operations and Manufacturing (ATOM) ...
read more
Thursday, January 08, 2015
Bob Hartwig, North American Representative for DIR Technologies – a provider of quality and process control solutions for pharmaceutical primary packaging – will deliver a presentation at Pack Expo East on the potential of disruptive technology and ...
read more
Monday, February 09, 2015
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, will introduce a new label + cap combination anti-counterfeiting solution to the U.S. market at INTERPHEX NYC 2015 Booth #1053, ...
read more
Asymchem Laboratories announced that it has officially inaugurated its new European development and pilot manufacturing site at Discovery Park in Sandwich, Kent, U.K., marked with a ribbon cutting by Dr. Hao Hong, Chairman, Founder, and CEO of ...
read more
Wednesday, March 31, 2021
Asymchem has announced a dedicated expansion of API manufacturing facilities to provide clients with peptide and oligonucleotide products.
read more
Wednesday, April 06, 2022
Asymchem Laboratories (Tianjin) Co., Ltd. announced the company has completed construction of a new building at its Dunhua, China, production site. The expansion will add nearly 500m³ of batch capacity to meet demands for upcoming commercialization ...
read more
Asymchem announced its Tianjin1 site successfully completed a FDA general GMP reinspection conducted between January 14-18, 2019. No Form 483 was issued.
read more